https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-04-21 / J Transl Med 2020 04;18(1):176
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-04-21 / J Transl Med 2020 04;18(1):1762020-04-21 00:00:002021-05-19 12:39:42Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-04-07 / Clin Transl Oncol 2020 Apr;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-04-07 / Clin Transl Oncol 2020 Apr;2020-04-07 00:00:002020-04-07 00:00:00Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-04-01 / J Immunother Cancer 2020 Apr;8(1)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-04-01 / J Immunother Cancer 2020 Apr;8(1)2020-04-01 00:00:002020-04-01 00:00:00Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103 conventional dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-20 / Life Sci. 2020 Aug;254:117580
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-20 / Life Sci. 2020 Aug;254:1175802020-03-20 00:00:002020-03-20 00:00:00Dendritic cell therapy in cancer treatment; the state-of-the-art
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-16 / Cancer Cell 2020 03;37(3):289-307.e9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-16 / Cancer Cell 2020 03;37(3):289-307.e92020-03-16 00:00:002020-08-26 12:23:32Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-12 / Pharmaceutics 2020 Mar;12(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-12 / Pharmaceutics 2020 Mar;12(3)2020-03-12 00:00:002020-08-26 13:44:51Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-12 / Front Oncol 2020;10:343
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-12 / Front Oncol 2020;10:3432020-03-12 00:00:002020-03-12 00:00:00Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-06 / Biomedicines 2020 Mar;8(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-06 / Biomedicines 2020 Mar;8(3)2020-03-06 00:00:002021-11-15 17:52:40New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-05 / Cancers (Basel) 2020 Mar;12(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-05 / Cancers (Basel) 2020 Mar;12(3)2020-03-05 00:00:002020-08-26 13:47:31Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-04 / Biomed. Pharmacother. 2020 Jun;126:110046
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-04 / Biomed. Pharmacother. 2020 Jun;126:1100462020-03-04 00:00:002020-03-04 00:00:00Dendritic cell vaccine for the effective immunotherapy of breast cancer
